期刊文献+

肺癌组织中高迁移率族蛋白-1、血管内皮生长因子和基质金属蛋白酶-9与微血管生成的相关性研究 被引量:6

The correlation of HMGB-1,VEGF and MMP-9 with angiogenesis in lung cancer tissue
原文传递
导出
摘要 目的 探讨肺癌组织中高迁移率族蛋白-1(HMGB-1)、VEGF和MMP-9与微血管生成的相关性.方法 选择肺癌患者标本80例为研究对象,癌组织作为观察组,癌旁正常肺组织作为对照组,采用免疫组化染色测定组织中HMGB-1、VEGF、MMP-9和MVD的表达情况.结果 观察组肺组织HMGB-1、VEGF和MMP-9的表达均明显高于对照组(χ^2=6.27、5.93、5.16,均P<0.05).观察组MVD值为(76.27±19.24)个,对照组为(24.67±6.14)个,两组差异有统计学意义(t=6.764,P<0.01).HMGB-1、VEGF和MMP-9均与MVD呈正相关关系(r=0.430、0.506、0.597,均P<0.05).结论 肺癌组织中HMGB-1、VEGF和MMP-9与微血管生成有密切关系. Objective To study the correlation of high mobility group box-1 ( HMGB-1 ), vascular endothelial growth factor ( VEGF ) and matrix metalloproteinase-9 ( MMP-9 ) with angiogenesis in lung cancer tissue. Methods The lung tissues of 80 cases with non-small cell lung cancer were selected. The cancerous tissues were enrolled into the observation group, and adjacent tissues were selected as the control group. HMGB-1, VEGF, MMP-9 and MVD expression were determined by immunohistochemical staining. Results The expressions of HMGB-1, VEGF and MMP-9 in the observation group were significantly higher than those in the control group( ~2 = 6.27,5.93,5.16, all P 〈 0.05 ). MVD value of the observation group was (76.27 + 19.24 ), that of the control group was (24.67 + 6. 14) ,there was significant difference between the two groups (t = 6. 764, P 〈 0.01 ). HMGB-1, VEGF and MMP-9 were positively correlated with MVD ( r = 0. 430,0. 506,0. 597, all P 〈 0.05 ). Conclusion In lung cancer tissue, HMGB-1, VEGF and MMP-9 were closely related with angiogenesis.
作者 高红莉
出处 《中国基层医药》 CAS 2014年第3期346-348,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肺肿瘤 高迁移率族蛋白-1 血管内皮生长因子 基质金属蛋白酶-9 微血管密度 Lung neoplasm High mobility group box-1 Vascular endothelial growth factor Matrix metalloproteinase-9 Microvessel density
  • 相关文献

参考文献11

二级参考文献125

共引文献125

同被引文献41

  • 1陆再英.钟南山.内科学第七版[M].北京:人民卫生出版社,2008:350.
  • 2Shrivastava RK, Epstein FJ, Perin NI, et al. Intramedullary spinal cord tumors in patients older than 50 years of age management and outcome analysis [ J ]. J Neurosurg Spine, 2005,2 ( 3 ) : 249- 255.
  • 3Chi JH, Cachola K, Parsa AT. Genetics and molecular biology of intramedunary spinal cord tumors [ J ]. Neurosurg Clin N Am, 2006,17(1) :1-5.
  • 4Massard C, Loriot Y, Fizazi K. Cm'einomas of an unknown primary origin-diagnosis and treatment[ J]. Nat Rev Clin Oncol,2011,8 (12) :701-710.
  • 5Mesiano S, Ferrara N, Jaffe RB, et al. Role of vascular endothelial growth factor in ovarian cancer : inhibition of ascites formation by immunoneutralization [ J ]. Am J Pathol, 1998,153 (4) : 1249- 1256.
  • 6Lecorter J, Kowalski J, Foster J, et al. Indentification of an angio- genic mitogen selective for endocrine gland endothelium [ J ]. Na- ture ,2001,412 (6850) :877-884.
  • 7Pino MS, Milella M, Gelibter A, et al. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers[J]. Oncology,2009,76(4) :254-261.
  • 8Kaser A, Winkhnayr M, Lepperdinger G. The AVIT protein family secreted cysteine-rich vertebrate proteins with diverse functions [ J ]. EMBO Reports ,2003,4 ( 5 ) :469-473.
  • 9LeCouter J, Kowalski J, Foster J, et al. Identification of an anglo- genic mitogen selective for endocrine gland endothelium [ J ]. Na- ture ,2001,412 ( 6850 ) :877-884.
  • 10Goi T, Nakazawa T, Hirono Y, et al. Prokineticin 1 expression in gastrointestinal tumors [ J ]. Antieancer Res,2013,33 ( 12 ) : 5311 - 5315.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部